Grants and Contributions

The specific objectives of this funding opportunity are to:

Generate data and evidence to monitor and evaluate the potential benefits, harms, and unintended consequences of alcohol regulation on population health and health equity;
Generate intervention-related evidence to address the needs of knowledge users in this space, including for regulatory aims;
Facilitate consideration and application of new evidence to inform ongoing and future development of policies, practices and programs related to alcohol;
Support partnerships between researchers and knowledge users to rapidly inform policies and practices related to prevention, harm reduction, and treatment of alcohol use;
Encourage evaluation of interventions, population health intervention research, and implementation science approaches that consider sub-populations and/or the biological, structural, and social determinants of problematic alcohol use.

• The CIHR Institute of Infection and Immunity (CIHR-III) will fund applications that are determined to be specifically relevant to their mandate with a primary focus on biomedical research in which the objective and aims are directed towards building foundational knowledge in immunology and/or infectious diseases. This priority announcement will prioritize funding for research in the following research areas:
o Infection:
• Zoonotic or vector-borne transmission of pathogens in the context of Global Climate Change;
• Understanding functional genomics and/or molecular epidemiology of emerging/re-emerging pathogens;
• Resistance to fungal infections and/or the role of bacteriophages in combatting antimicrobial resistance (AMR)
o Immunity:
• Immune mechanisms involved in the development of trained innate immunity;
• Immune mechanisms involved in the development and maintenance of tissue-specific immunity;
• Metabolic regulation of immune cells and processes (immunometabolism)
• Should there be no eligible applications relevant to the research areas identified above, III will fund applications that are relevant to its mandate with a primary focus on biomedical research in which the objective and aims are directed towards building foundational knowledge in immunology and/or infectious diseases.

• The CIHR Institute of Infection and Immunity (CIHR-III) will fund applications that are determined to be specifically relevant to their mandate with a primary focus on biomedical research in which the objective and aims are directed towards building foundational knowledge in immunology and/or infectious diseases. This priority announcement will prioritize funding for research in the following research areas:
o Infection:
• Zoonotic or vector-borne transmission of pathogens in the context of Global Climate Change;
• Understanding functional genomics and/or molecular epidemiology of emerging/re-emerging pathogens;
• Resistance to fungal infections and/or the role of bacteriophages in combatting antimicrobial resistance (AMR)
o Immunity:
• Immune mechanisms involved in the development of trained innate immunity;
• Immune mechanisms involved in the development and maintenance of tissue-specific immunity;
• Metabolic regulation of immune cells and processes (immunometabolism)
• Should there be no eligible applications relevant to the research areas identified above, III will fund applications that are relevant to its mandate with a primary focus on biomedical research in which the objective and aims are directed towards building foundational knowledge in immunology and/or infectious diseases.

• The CIHR Institute of Infection and Immunity (CIHR-III) will offer funding to support early career investigators in the fields of infection and immunity.
• CIHR-III will award multi-year grants to applications that are determined to be specifically relevant to the CIHR-III broad mandate as described below:
o The Institute of Infection and Immunity (III) supports research and helps to build research capacity in the areas of infectious disease and the body's immune system. Through the Institute's programs, researchers address a wide range of health concerns related to infection and immunity including disease mechanisms, disease prevention and treatment, and health promotion through public policy.

The CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) will provide funding for applications in which the objectives and aims are determined to be largely and directly relevant to the INMD mandate as described below:
o CIHR-INMD supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions and problems associated with hormone, digestive system, kidney, and liver.
• These grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.

• Canada’s Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care. Its vision is that by 2025, Canada will have demonstrably improved health outcomes and enhanced the health care experience for patients through the integration of evidence at all levels of the health care system.
• As outlined in the SPOR Patient Engagement Framework, patient-oriented research refers to a continuum of research that engages patients as partners, focusses on patient-identified priorities and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve healthcare systems and practices.
• As a partner in SPOR, CIHR will provide bridge funding for fundable applications that are below the competition funding cut-off and aligned with the SPOR vision, the SPOR Patient Engagement Framework and the SPOR Capacity Development Framework. Categories are described in the Funds Available section.

• Canada’s Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care. Its vision is that by 2025, Canada will have demonstrably improved health outcomes and enhanced the health care experience for patients through the integration of evidence at all levels of the health care system.
• As outlined in the SPOR Patient Engagement Framework, patient-oriented research refers to a continuum of research that engages patients as partners, focusses on patient-identified priorities and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve healthcare systems and practices.
• As a partner in SPOR, CIHR will provide bridge funding for fundable applications that are below the competition funding cut-off and aligned with the SPOR vision, the SPOR Patient Engagement Framework and the SPOR Capacity Development Framework. Categories are described in the Funds Available section.

• Canada’s Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care. Its vision is that by 2025, Canada will have demonstrably improved health outcomes and enhanced the health care experience for patients through the integration of evidence at all levels of the health care system.
• As outlined in the SPOR Patient Engagement Framework, patient-oriented research refers to a continuum of research that engages patients as partners, focusses on patient-identified priorities and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve healthcare systems and practices.
• As a partner in SPOR, CIHR will provide bridge funding for fundable applications that are below the competition funding cut-off and aligned with the SPOR vision, the SPOR Patient Engagement Framework and the SPOR Capacity Development Framework. Categories are described in the Funds Available section.

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined to be relevant to the mandate and research priority areas of CIHR-IMHA as described below:
o Myalgic Encephalomyelitis (ME)
o IMHA Mandate Areas:
¿ Musculoskeletal Health
¿ Skin Health
¿ Oral Health
¿ Chronic Pain and Fatigue
¿ Inflammation and Tissue Repair
¿ Disability, Mobility and Health

The Institute of Population and Public Health (IPPH) will fund applications that are determined to be relevant to the mandate and research priority areas of CIHR-IPPH as described below:

Healthy Cities: Applications must be aligned with CIHR’s Healthy Cities Research Initiative (HCRI) and be focused on population health intervention research and/or implementation science as it relates to urban environments.
Equitable AI: Applications must be aligned with IPPH’s Equitable AI Initiative and focused on exploring the use of artificial intelligence (AI) approaches or development of AI tools, to address public health challenges and promote health equity (*). IPPH is particularly interested in projects exploring the compounding influences of AI on public health at the intersections of various social determinants of health, including but not limited to sex and gender, race, ethnicity, Indigenous identity, and disability.
Global Health Policy: Applications must be focused on research areas within the mandate of IPPH and must be aligned with CIHR’s definition of global health and with the Canadian Coalition for Global Health Research’s Principles for Global Health Research.
* Health Equity: The term ‘health equity’ is used to refer to the belief that “all people can reach their full health potential and should not be disadvantaged from attaining it because of their race, ethnicity, gender, age, social class, language and minority status, socio-economic status, or other socially-determined circumstance.”